Takeshi Masuda

Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads

Takashi Nakada, Takeshi Masuda, Hiroyuki Naito et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 152 citations

Medicine, Radiation Oncology, Antibody Engineering +1

Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis

Kosuke Hamai, Hiroshi Iwamoto, Nobuhisa Ishikawa et al. · Disease Markers · 2016 · 146 citations · Full text

Inflammatory Lung Disease, Advanced Lung Disease, Lung Inflammation +17

Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer

Yu Nakanishi, Takeshi Masuda, Kakuhiro Yamaguchi et al. · Respiratory Investigation · 2019 · 113 citations

Advanced Lung Disease, Medicine, Multiple Pulmonary Nodule +7

Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy

Takeshi Masuda, Noboru Hattori, Akinobu Hamada et al. · Cancer Chemotherapy and Pharmacology · 2011 · 96 citations

Cerebrospinal Fluid Concentration, Medicine, Lung Adenocarcinoma +8

XBP1-FoxO1 interaction regulates ER stress-induced autophagy in auditory cells

Akihiro Kishino, Ken Hayashi, Chiaki Hidai et al. · Scientific Reports · 2017 · 78 citations · Full text